newsfilter
← Latest News
Business Wire·

Kiromic BioPharma Welcomes Two New Directors to its Board

Clinical and Regulatory Affairs Expert Pamela Misajon Brings Drug-Development Expertise Finance and Technology Executive Michael Catlin to Chair the Audit Committee Kiromic BioPharma, Inc. (NASDAQ:KRBP) ("Kiromic"